Overview
Background
Dr Andrew Burke currently works with the UQ Centre for Clinical Research, The University of Queensland and is dual specialist in both infectious diseases and thoracic medicine at The Prince Charles Hospital, Brisbane. He has diverse clinical experience in low income countries and regional Australia and holds a Diploma in Tropical Medicine and Hygiene (Liverpool) and a Masters in Public Health from the University of Queensland.
Andrew is a principal investigator on a number of industry lead trials for pulmonary NTM infection. He is an associate investigator on the FORMAT study assessing clinical outcomes in pulmonary Mycobacterium abscessus infection and with Professor Jason Roberts of UQCCR is leading the pharmacokinetic sub-studies in this multi-national trial.
Andrew is on the Australian Therapeutic Guidelines writing groups for both antibiotics and respiratory disease. He is current chair of the steering committee of the Australasian Clinical Tuberculosis network (ACTnet) and is on the Queensland Tuberculosis Expert Advisory Group. He is currently undertaking a PhD in the pharmacokinetics of mycobacterial drugs in people with tuberculosis and cystic fibrosis. As part of his PhD he is exploring the role of therapeutic drug montioring in complex mycobacterial infections and sees great potential for Australian and Asia-Pacific researchers to contribute to mycobacterial research through involvement in PK studies.
Availability
- Dr Andrew Burke is:
- Available for supervision
Works
Search Professor Andrew Burke’s works on UQ eSpace
2014
Journal Article
Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery
Piccolo, Francesco, Pitman, Nicholas, Bhatnagar, Rahul, Popowicz, Natalia, Smith, Nicola A., Brockway, Ben, Nickels, Robert, Burke, Andrew J., Wong, Conroy A., McCartney, Ruth, Choo-Kang, Brian, Blyth, Kevin G., Maskell, Nick A. and Lee, Y. C. Gary (2014). Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Annals of the American Thoracic Society, 11 (9), 1419-1425. doi: 10.1513/AnnalsATS.201407-329OC
2013
Conference Publication
Personalized care for COPD: the "COPD Snapshot"
Hakim, R., Mccarthy, L., Masel, P. J., Bowman, R. V., Burke, A., Bazdar, S., Serginson, J. G. and Yang, I. A. (2013). Personalized care for COPD: the "COPD Snapshot". Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2013 Annual Scientific Meetings, Darwin, NT, Australia, 22-27 March 2013. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/resp.12045
2012
Conference Publication
Bronchoscopy and Transthoracic-Needle Aspiration Yield for Histomorpho-Molecular Diagnosis
Daniels, M. G., Leong, S., Bowman, R. V., Yang, I. A., Masel, P., Fiene, A., Robinson, P., Burke, A., McKeon, J., Ayres, J., Duhig, E., Clarke, B., Tran, K., Godbolt, D., Dettrick, A. and Fong, K. M. (2012). Bronchoscopy and Transthoracic-Needle Aspiration Yield for Histomorpho-Molecular Diagnosis. 4th Australian Lung Cancer Conference, Adelaide Australia, 23-25 August 2012. New York, NY, United States: Elsevier.
2012
Journal Article
Infective Endocarditis and Rheumatic Heart Disease in the North of Australia
Baskerville, Catherine A., Hanrahan, Brendan B., Burke, Andrew J., Holwell, Anna J., Remond, Marc G. W. and Maguire, Graeme P. (2012). Infective Endocarditis and Rheumatic Heart Disease in the North of Australia. Heart Lung and Circulation, 21 (1), 36-41. doi: 10.1016/j.hlc.2011.08.010
2011
Conference Publication
Community Acquired Respiratory Viral Infection Is a Risk Factor for Death after Lung Transplantation
Chambers, D. C., Burke, A., Daniels, T. W. V., Yerkovich, S. T. and Hopkins, P. M. A. (2011). Community Acquired Respiratory Viral Infection Is a Risk Factor for Death after Lung Transplantation. 31st Annual Meeting and Scientific Sessions on International-Society-for-Heart-and-Lung-Transplantation, San Diego CA, United States, 13-16 April 2011. New York, NY, United States: Elsevier. doi: 10.1016/j.healun.2011.01.360
Supervision
Availability
- Dr Andrew Burke is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Dr Andrew Burke's areas of expertise, story ideas and help finding experts, contact our Media team: